Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival

被引：30

作者：

Galleu, Antonio ^{[1
,2
]}

Milojkovic, Dragana ^{[3
]}

Deplano, Simona ^{[3
]}

Szydlo, Richard ^{[4
]}

Loaiza, Sandra ^{[3
]}

Wynn, Robert ^{[5
]}

Marks, David I. ^{[6
]}

Richardson, Deborah ^{[7
]}

Orchard, Kim ^{[7
]}

Kanfer, Edward ^{[3
]}

Tholouli, Eleni ^{[5
]}

Saif, Muhammad ^{[5
]}

Sivaprakasam, Ponni ^{[6
]}

Lawson, Sarah ^{[8
]}

Bloor, Adrian ^{[9
]}

Pagliuca, Antonio ^{[10
]}

Potter, Victoria ^{[10
]}

Mehra, Varun ^{[10
]}

Snowden, John A. ^{[11
]}

Vora, Ajay ^{[12
]}

Kishore, Bhuvan ^{[13
]}

Hunter, Hannah ^{[14
]}

Apperley, Jane F. ^{[3
,4
]}

Dazzi, Francesco ^{[1
,2
,3
,4
]}

机构：

[1] Kings Coll London, London, England

[2] Kings Hlth Partners Canc Res UK Ctr, London, England

[3] Imperial Coll Healthcare NHS Trust, London, England

[4] Imperial Coll London, London, England

[5] Cent Manchester Univ Hosp, Manchester, Lancs, England

[6] Univ Hosp Bristol, Bristol, Avon, England

[7] Southampton Univ Hosp, Southampton, Hants, England

[8] Birmingham Womens & Childrens Hosp, Birmingham, W Midlands, England

[9] Christie NHS Fdn Trust, Manchester, Lancs, England

[10] Kings Coll Hosp NHS Trust, London, England

[11] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[12] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England

[13] NHS Fdn Trust, Heart England, Birmingham, W Midlands, England

[14] Plymouth Hosp NHS Trust, Plymouth, Devon, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 01期

关键词：

cellular therapies; GvHD; mesenchymal cells; clinical research; stromal cells; STEM-CELLS; STEROID-RESISTANT; ACUTE GVHD; GRADE III; THERAPY;

D O I：

10.1111/bjh.15749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MSC infusion predict patients' overall survival. In our cohort, cell dose, patients' age and type of organ involvement are crucial factors associated with clinical responses.

引用

页码：89 / 92

页数：4

共 50 条

[41] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
Ardizzoia, Federica
Lorentino, Francesca
Bruno, Alessandro
Marktel, Sarah
Giglio, Fabio
Clerici, Daniela
Farina, Francesca
Mastaglio, Sara
Piemontese, Simona
Assanelli, Andrea A.
Carrabba, Matteo G.
Bernardi, Massimo
Corti, Consuelo
Peccatori, Jacopo
Ciceri, Fabio
Greco, Raffaella
Lupo-Stanghellini, Maria Teresa
HAEMATOLOGICA, 2022, 107 (11) : 2748 - 2751
[42] Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
Zhou, Xinyi
Jin, Nan
Wang, Fei
Chen, Baoan
CANCER CELL INTERNATIONAL, 2020, 20 (01)
[43] Use of mesenchymal stem cells as treatment for graft-versus-host disease: current knowledge and controversies
Ortin, Miguel
Sierra, Jorge
IMMUNOTHERAPY, 2011, 3 (06) : 701 - 704
[44] IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease
Li, Hui
Liu, Qi
Gao, Xiaofeng
Zhang, Di
Mao, Shengjun
Jia, Yongqian
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 592
[45] Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis
Morata-Tarifa, Cynthia
Macias-Sanchez, Maria del Mar
Gutierrez-Pizarraya, Antonio
Sanchez-Pernaute, Rosario
STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
[46] Acute graft-versus-host disease
Malard, Florent
Holler, Ernst
Sandmaier, Brenda M.
Huang, He
Mohty, Mohamad
NATURE REVIEWS DISEASE PRIMERS, 2023, 9 (01)
[47] Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease
Christensen, Melinda E.
Turner, Brie E.
Sinfield, Laura J.
Kollar, Katarina
Cullup, Hannah
Waterhouse, Nigel J.
Hart, Derek N. J.
Atkinson, Kerry
Rice, Alison M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (12): : 2102 - 2110
[48] Adult adherent stromal cells in the management of graft-versus-host disease
Newell, Laura F.
Deans, Robert J.
Maziarz, Richard T.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 231 - 246
[49] Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
Hashmi, Shahrukh
Ahmed, Mohammad
Murad, M. Hassan
Litzow, Mark R.
Adams, Roberta H.
Ball, Lynne M.
Prasad, Vinod K.
Kebriaei, Partow
Ringden, Olle
LANCET HAEMATOLOGY, 2016, 3 (01): : E45 - E52
[50] Graft-versus-Host Disease Treatment: Predictors of Survival
Levine, John E.
Logan, Brent
Wu, Juan
Alousi, Amin M.
Ho, Vincent
Bolanos-Meade, Javier
Weisdorf, Daniel
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1693 - 1699

← 1 2 3 4 5 →